Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

NICE Ltd. (NICE) Balance Sheet

As of 2025-12-31 (20-F), NICE Ltd. (NICE) reported total assets of $5.1B and shareholders' equity of $3.9B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $379.4M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

Software - Application · Technology
—
Price chart with a free account
Market cap
7.3B
Annual P/E
—
Dividend yield
—
52-week
—
Next earnings
12 Nov, in 19 days
LineFY2009
Dec 09
FY2010
Dec 10
FY2011
Dec 11
FY2012
Dec 12
FY2013
Dec 13
FY2014
Dec 14
FY2015
Dec 15
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Dec 25
Trend
Cash and equivalents0.210.110.200.100.120.190.330.160.330.240.230.440.380.530.510.480.380.38
Short-term investments0.070.240.140.200.080.070.100.030.060.240.211.021.051.040.901.140.040.04
Receivables0.100.100.130.160.190.160.180.260.230.290.320.300.400.520.590.640.740.74
Inventory0.010.010.010.010.010.010.010.000.000.000.00———————
Current assets0.470.500.540.520.460.490.660.510.690.860.881.942.302.422.312.501.381.38
Total assets1.401.531.581.661.661.631.852.632.853.213.614.234.714.855.125.305.115.11
Current liabilities0.290.330.370.380.380.380.380.470.520.620.941.041.271.141.121.470.890.89
Long-term debt———————0.440.450.460.210.420.430.460.460.00——
Short-term debt———————0.02—0.000.250.260.400.210.210.460.000.00
Shareholders' equity1.061.161.161.191.201.211.421.511.752.022.262.562.833.043.343.593.883.88

USD billions · SEC XBRL

NICE Ltd. — questions

How much cash does NICE Ltd. have?
$379.4M in cash and cash equivalents as of 2025-12-31.
How much debt does NICE Ltd. have?
$0 due within a year as of 2025-12-31.
What are NICE Ltd.'s total assets?
$5.1B as of 2025-12-31.
What is NICE Ltd.'s shareholders' equity?
$3.9B as of 2025-12-31.

Every figure on this page comes from NICE Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.